Literature DB >> 11120697

Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.

S Wiese1, T Breyer, A Dragu, R Wakili, T Burkard, S Schmidt-Schweda, E M Füchtbauer, U Dohrmann, F Beyersdorf, D Radicke, C J Holubarsch.   

Abstract

BACKGROUND: We studied the effects of angiotensin II (Ang II) and diastolic overstretch on the induction of cardiac growth in isometrically contracting muscle preparations from human right atria and left ventricles. We used the gene expression of brain natriuretic peptide (BNP) as a molecular marker of cardiac hypertrophy. METHODS AND
RESULTS: Northern blot analysis was performed in human atrial muscle preparations, which were either incubated in 10(-6) mol/L Ang II for 45 minutes or diastolically stretched to 120% of optimum muscle length. Similar experiments were performed with human left ventricular muscle preparations. Results were as follows: (1) BNP gene expression increased in human atrial myocardium 4-fold when stimulated by Ang II (n=7, P<0.001). (2) Diastolic overstretch increased BNP expression in a time-dependent manner. The linear regression equations for the BNP/GAPDH ratio as a function of time (hours) were y=1.21+0.62x (P:<0.001) for overstretched preparations and y=1.07-0.01x (P:=NS) for atrial preparations kept at physiological muscle length. (3) In left ventricular human muscle preparations, diastolic overstretch and Ang II increased BNP gene expression as well. (4) In addition, the Ang II subtype 1 receptor blocker losartan was able to block the effects of Ang II and diastolic overstretch.
CONCLUSIONS: Cardiac hypertrophy can be induced in isolated human atrial and left ventricular intact myocardium by Ang II and diastolic overstretch but not by isometric afterload. The fact that the induction of cardiac growth is inhibited by the blockade of Ang II subtype 1 receptors is of scientific and clinical importance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120697     DOI: 10.1161/01.cir.102.25.3074

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

1.  B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin.

Authors:  Lluís Zapata; Paula Vera; Antoni Roglan; Ignasi Gich; Jordi Ordonez-Llanos; Antoni J Betbesé
Journal:  Intensive Care Med       Date:  2010-12-09       Impact factor: 17.440

Review 2.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure.

Authors:  O Gosling; M Martin; E Clarke; A Smith; E Coombes; M Dawes
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

4.  Evaluation of heart function with impedance cardiography in acute myocardial infarction patients.

Authors:  Shun-Juan Chen; Zhu Gong; Qiang-Lin Duan
Journal:  Int J Clin Exp Med       Date:  2014-03-15

5.  Association between BNP levels and new-onset atrial fibrillation : A propensity score approach.

Authors:  Y Karabağ; I Rencuzogullari; M Çağdaş; S Karakoyun; M Yesin; M Uluganyan; M O Gürsoy; İnanç Artaç; Doğan İliş; Tayyar Gökdeniz; S Ç Efe; O Taşar; H I Tanboğa
Journal:  Herz       Date:  2017-07-13       Impact factor: 1.443

6.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 7.  Natriuretic peptides in heart valve disease.

Authors:  S G Ray
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

Review 8.  Diagnosis and management of atherosclerotic renal artery stenosis: improving patient selection and outcomes.

Authors:  Christopher J White; Jeffrey W Olin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

9.  Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.

Authors:  S Yi; G Contreras; E R Miller; L J Appel; B C Astor
Journal:  Am J Nephrol       Date:  2008-09-29       Impact factor: 3.754

10.  Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.

Authors:  Felix M Heidrich; Kun Zhang; Manuel Estrada; Yan Huang; Frank J Giordano; Barbara E Ehrlich
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.